APP and Alzheimer disease: Interestingly, studies have shown that miR-107 downregulated beta amyloid cleaving enzyme (BACE1), which generated amyloid beta peptide (Aβ) fragments by cleaving APP, leading to amyloid beta deposition promoting the development of AD [91].